drugset / Trial / NCT00635882

Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1)(COMPLETED)

NCT00635882

Phase 2 Completed 93 enrolled Organon and Co
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a 2-week double-blind, placebo-controlled, parallel group study comparing the anti-inflammatory effects of low, medium, and high dose mometasone furoate/formoterol fumarate (MF/F) metered dose inhaler (MDI) formulation and medium dose mometasone furoate (MF) dry powder inhaler (DPI) and MDI formulations in adults and adolescents with persistent allergic asthma.

Timeline

Start
2008-02
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Formoterol Other / unclassified 10 ug Inhaled
Subject Mometasone furoate Other / unclassified 100 ug Inhaled
Subject Mometasone furoate Other / unclassified 200 ug Inhaled
Subject Mometasone furoate Other / unclassified 400 ug Inhaled

Indications